4,313 results on '"Akpek EK"'
Search Results
202. Medical management of acutely recurring pterygium with topical mitomycin-C.
- Author
-
Adyanthaya RS, Folgar FA, and Akpek EK
- Subjects
- Acute Disease, Administration, Topical, Adult, Alkylating Agents adverse effects, Female, Humans, Male, Middle Aged, Mitomycin adverse effects, Prospective Studies, Pterygium etiology, Recurrence, Treatment Outcome, Alkylating Agents administration & dosage, Mitomycin administration & dosage, Pterygium drug therapy
- Published
- 2009
- Full Text
- View/download PDF
203. [Differential diagnoses of ocular mucous membrane pemphigoid].
- Author
-
Steven P
- Subjects
- Humans, Conjunctiva pathology, Cicatrix diagnosis, Diagnosis, Differential, Mucous Membrane pathology, Pemphigoid, Bullous diagnosis, Pemphigoid, Benign Mucous Membrane diagnosis
- Abstract
Overall, conjunctival scarring is rare and often overlooked during routine examination. However, the differential diagnostic distinction of cicatricial mucous membrane pemphigoid from other causes is crucial for further treatment planning. Other entities that lead to conjunctival scarring, are ocular rosacea, ocular graft-versus-host disease, atopic keratoconjunctivitis, infections, trauma and further sometimes very rare diseases. Most of these differential diagnoses have in common that conjunctival scarring does not progress indefinitely if untreated, in contrast to mucous membrane pemphigoid., (© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
204. Knockout of miR-184 in zebrafish leads to ocular abnormalities by elevating p21 levels.
- Author
-
Zhang J, Li P, Sun L, Jiang N, Guo W, Wang J, Gao F, Li J, Li H, Zhang J, Mu H, Hu Y, and Cui X
- Subjects
- Animals, Transcription Factors metabolism, Zebrafish genetics, Cataract genetics, Cataract metabolism, Lens, Crystalline metabolism, MicroRNAs genetics, MicroRNAs metabolism
- Abstract
miR-184 is one of the most abundant miRNAs expressed in the lens and corneal tissue. Mutations in the seed region of miR-184 are responsible for inherited anterior segment dysgenesis. Animal models recapitulating miR-184-related anterior segment dysgenesis are still lacking, and the molecular basis of ocular abnormalities caused by miR-184 dysfunction has not been well elucidated in vivo. In the present study, we constructed a miR-184
-/- zebrafish line by destroying both two dre-mir-184 paralogs with CRISPR-Cas9 technology. Although there were no gross developmental defects, the miR-184-/- zebrafish displayed microphthalmia and cataract phenotypes. Cytoskeletal abnormalities, aggregation of γ-crystallin, and lens fibrosis were induced in miR-184-/- lenses. However, no obvious corneal abnormalities were observed in miR-184-/- zebrafish. Instead of apoptosis, deficiency of miR-184 led to aberrant cell proliferation and a robust increase in p21 levels in zebrafish eyes. Inhibition of p21 by UC2288 compromised the elevation of lens fibrosis markers in miR-184-/- lenses. RNA-seq demonstrated that levels of four transcriptional factors HSF4, Sox9a, CTCF, and Smad6a, all of which could suppress p21 expression, were reduced in miR-184-/- eyes. The predicted zebrafish miR-184 direct target genes (e.g., atp1a3a and nck2a) were identified and verified in miR-184-/- eye tissues. The miR-184-/- zebrafish is the first animal model mimicking miR-184-related anterior segment dysgenesis and could broaden our understanding of the roles of miR-184 in eye development., (© 2023 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.)- Published
- 2023
- Full Text
- View/download PDF
205. Electron microscopic investigation of the lens capsule and conjunctival tissues in individuals with clinically unilateral pseudoexfoliation syndrome.
- Author
-
Parekh P, Green WR, Stark WJ, and Akpek EK
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Microscopy, Electron, Middle Aged, Prospective Studies, Conjunctiva pathology, Exfoliation Syndrome pathology, Lens Capsule, Crystalline pathology
- Abstract
Purpose: To determine the presence of pseudoexfoliative material in the unaffected eyes of patients with clinically unilateral pseudoexfoliation syndrome., Design: Prospective observational case series., Participants: Thirty-two consecutive patients with clinically unilateral pseudoexfoliation syndrome, undergoing routine cataract surgery., Methods: Transmission electron microscopy (TEM) was used to examine conjunctival and anterior lens capsule specimens in affected and unaffected eyes., Main Outcome Measure: Presence of characteristic pseudoexfoliation syndrome findings on TEM., Results: Transmission electron microscopy demonstrated pseudoexfoliative material on either the anterior capsule or conjunctival sample from the clinically unaffected eye in 26 of the 32 patients with clinically unilateral pseudoexfoliation syndrome (81%; 95% confidence interval, 64%-93%)., Conclusion: The results suggest that the seemingly uninvolved eye in a patient with clinically unilateral pseudoexfoliation syndrome has an 81% likelihood of being affected ultrastructurally. Several population studies examining conversion rates from unilateral to bilateral disease have found a similar proportion of patients with bilateral pseudoexfoliation syndrome in the later decades of life.
- Published
- 2008
- Full Text
- View/download PDF
206. Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice.
- Author
-
Jabs DA, Prendergast RA, Campbell AL, Lee B, Akpek EK, Gérard HC, Hudson AP, and Whittum-Hudson JA
- Subjects
- Animals, Autoimmune Diseases pathology, B7-1 Antigen metabolism, B7-2 Antigen metabolism, Dacryocystitis pathology, Female, Immunoenzyme Techniques, Interferon-gamma genetics, Interferon-gamma metabolism, Interleukin-13 genetics, Interleukin-13 metabolism, Male, Mice, Mice, Inbred BALB C, Mice, Inbred MRL lpr, Mice, Knockout, RNA, Messenger metabolism, Reverse Transcriptase Polymerase Chain Reaction, Autoimmune Diseases immunology, Dacryocystitis immunology, Gene Silencing physiology, Interleukin-4 genetics, Th1 Cells immunology, Th2 Cells immunology
- Abstract
Purpose: MRL/MpJ mice of substrains MRL/MpJ-fas(+)/fas(+) (MRL/+) and MRL/MpJ-fas(lpr)/fas(lpr) (MRL/lpr) spontaneously develop autoimmune dacryoadenitis and sialadenitis and are a model for the human disorder Sjögren syndrome. The dacryoadenitis in both substrains appears to be Th2 in nature, with little IFN-gamma and substantial IL-4 at the site of lacrimal gland inflammation., Methods: MRL/MpJ mice with a defective IL-4 gene-both MRL/+-IL-4(tm)/IL-4(tm) (MRL/+/IL-4(tm)) and MRL/lpr-IL-4(tm)/IL-4(tm) (MRL/lpr-IL-4(tm))-that resulted in a loss of IL-4 production were bred and evaluated for dacryoadenitis., Results: MRL/+/IL-4(tm) and MRL/lpr/IL-4(tm) mice developed dacryoadenitis of similar onset, appearance, and severity as found in MRL/MpJ mice with an intact IL-4 gene. Immunohistochemistry examination revealed a substantially greater number of inflammatory cells staining for IFN-gamma than for IL-13 in the dacryoadenitis of IL-4-deficient MRL/MpJ mice (MRL/+/IL-4(tm), 66% vs. 0.8%, P = 0.001; MRL/lpr/IL-4(tm), 67% vs. 1.2%, P = 0.002). Real-time PCR demonstrated greater amounts of IFN-gamma than IL-13 mRNA relative transcripts in lacrimal glands of MRL/lpr/IL-4(tm) mice (mean difference, 28.6; P = 0.035). Greater CD86 (B7-2) than CD80 (B7-1) expression was present in MRL/+/IL-4(tm) mice (11% vs. 3%, P = 0.003) and MRL/lpr/IL-4(tm) mice (10% vs. 3%, P = 0.002)., Conclusions: These results suggest that a Th2 autoimmune process can be converted to a Th1 process in the absence of IL-4.
- Published
- 2007
- Full Text
- View/download PDF
207. Histopathologic and immunologic aspects of alphacor artificial corneal failure.
- Author
-
Coassin M, Zhang C, Green WR, Aquavella JV, and Akpek EK
- Subjects
- Aged, Corneal Diseases surgery, Device Removal, Female, Fluorescent Antibody Technique, Indirect, Humans, Male, Microscopy, Electron, Transmission, Middle Aged, Postoperative Complications, Artificial Organs, Biocompatible Materials, Cornea, Corneal Diseases immunology, Corneal Diseases pathology, Cytokines immunology, Prosthesis Failure
- Abstract
Purpose: To describe the histopathologic and immunologic characteristics of late artificial corneal failure in a small series of patients who underwent AlphaCor implantation and to elucidate the mechanisms involved., Design: Clinicopathologic case series., Methods: Three patients were diagnosed with corneal melting during the late postoperative period and required the removal of the devices. The explanted devices embedded within the corneal tissues were examined by light microscopy, electron microscopy, and immunohistochemical studies., Results: Light microscopic examination of the specimens disclosed adequate biointegration with no foreign body response. Immunofluorescence studies of the skirt exhibited expression of inflammatory cytokines such as interleukin-1beta (IL-1beta) and tumor necrosis factor alpha (TNF-alpha), and some interferon gamma (IFN-gamma). The keratocytes stained positively for Thy-1 and smooth muscle actin but negatively for CD34., Conclusions: Although these findings confirm the occurrence of biointegration, myofibroblastic differentiation of the ingrowing keratocytes is a prominent feature.
- Published
- 2007
- Full Text
- View/download PDF
208. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study.
- Author
-
Akpek EK, Harissi-Dagher M, Petrarca R, Butrus SI, Pineda R 2nd, Aquavella JV, and Dohlman CH
- Subjects
- Adult, Aged, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prosthesis Design, Retrospective Studies, Time Factors, Treatment Outcome, Visual Acuity, Aniridia surgery, Cornea, Prostheses and Implants, Prosthesis Implantation instrumentation
- Abstract
Purpose: To evaluate the long-term outcomes of keratoprosthesis as an alternative surgical procedure in the management of aniridic keratopathy., Design: Retrospective, multicenter case series., Methods: Fifteen adult patients (16 eyes) with aniridia who were deemed at high risk for regular donor corneal transplantation underwent a Boston type I keratoprosthesis procedure for visual rehabilitation. Device retention rate, preoperative and postoperative visual acuity, and intraoperative and postoperative complications were studied., Results: The mean age of the patients was 45 (median 50) years. Six of the patients were females. Eleven patients had previously undergone donor corneal transplantations (average two grafts), with failure. In 10 patients, the keratoprosthesis surgery was combined with other procedures such as cataract extraction, tube shunt implantation, vitrectomy, and intraocular lens removal. No intraoperative complications were encountered. The follow-up ranged from two months to 85 months, with a median of 17 months. All devices remained in situ throughout the entire follow-up period. The visual acuity improved in all but one patient from a median of counting fingers (light perception to 20/300) to 20/200 (hand motions to 20/60). Comorbid preoperative conditions particularly optic nerve and foveal hypoplasia limited the final postoperative vision. No endophthalmitis or extrusion of the device occurred. One device required repair procedure without necessitating a removal., Conclusions: Keratoprosthesis offers significant vision benefits in this patient group.
- Published
- 2007
- Full Text
- View/download PDF
209. Pediatric keratoprosthesis.
- Author
-
Aquavella JV, Gearinger MD, Akpek EK, and McCormick GJ
- Subjects
- Child, Child, Preschool, Female, Follow-Up Studies, Graft Survival physiology, Humans, Infant, Intraocular Pressure physiology, Intraoperative Complications, Male, Postoperative Complications, Refraction, Ocular physiology, Retrospective Studies, Visual Acuity physiology, Corneal Opacity surgery, Prostheses and Implants, Prosthesis Implantation
- Abstract
Objective: To describe the authors' experience using keratoprosthesis to treat pediatric corneal opacity., Design: Nonrandomized, consecutive, retrospective interventional series., Participants: Twenty-two eyes of 17 children with opaque corneas as a result of primary congenital disease and or previous failed keratoplasty., Methods: A retrospective review of pediatric patients with a history of corneal opacification treated with keratoprosthesis surgery., Main Outcome Measures: Intraocular pressure, inflammation, clarity of the visual axis, visual acuity, refraction, complications, and retention of the prosthesis., Results: Twenty-two eyes of 17 patients 1.5 to 136 months of age underwent 23 keratoprosthesis procedures. The follow-up period was 220 patient months (range, 1-37 months; mean, 9.7 months). In both cases implanted with the AlphaCor (Argus Biomedical Pty. Ltd., Perth, Australia), the keratoprosthesis was not retained. In one instance, the prosthesis sustained traumatic dislocation and was replaced with a cadaver cornea. In the second instance, the intralamellar implant began to extrude and was replaced with a Boston keratoprosthesis. In all 21 Boston cases, the prosthesis was retained without dislocation or extrusion. The visual axis remained clear in 100% of cases, although retroprosthetic membranes were removed in 5 eyes. Reoperation was necessitated for management of concurrent glaucoma (n = 3) or retinopathy (n = 2). There were no instances of surface infection or endophthalmitis. In 7 instances where patient age was 4 years or more, visual acuity ranged from counting fingers to 20/30. In the remaining cases, all infants were able to follow light, fingers, and objects. Intraocular pressure was controlled in all cases., Conclusions: Implantation of the Boston keratoprosthesis rapidly establishes and maintains a clear optical pathway and does not prejudice management of concurrent glaucoma or retinopathy. The device is retained without extrusion or rejection and is appropriate for the management of pediatric corneal opacity.
- Published
- 2007
- Full Text
- View/download PDF
210. Subluxation of suture-fixated posterior chamber intraocular lenses a clinicopathologic study.
- Author
-
Parekh P, Green WR, Stark WJ, and Akpek EK
- Subjects
- Device Removal, Humans, Iris surgery, Male, Microscopy, Electron, Scanning, Middle Aged, Polypropylenes, Prospective Studies, Foreign-Body Migration etiology, Lenses, Intraocular, Prosthesis Failure, Suture Techniques, Sutures
- Abstract
Purpose: To report the occurrence of subluxation of suture-fixated posterior chamber (PC) intraocular lenses (IOL) and elucidate the mechanisms involved., Design: Prospective clinicopathologic study., Participants: A single 10-0 Prolene suture explanted from a patient who experienced subluxation of his PC-IOL, 11.5 years after placement. Furthermore, multiple 10-0 Prolene sutures and PC-IOLs used for iris fixation were studied as controls., Methods: Scanning electron microscopy (SEM) was used to analyze the surface of the explanted suture. In addition, randomly selected 10-0 Prolene sutures cut with Vannas scissors and cut with the positioning holes of a randomly selected PC-IOL identical to that implanted in the patient's eye were examined as controls. Finally, the positioning holes of several randomly selected, iris-fixated PC-IOLs were studied using SEM with particular attention to surface quality and edge finish., Main Outcome Measures: Presence of any signs of suture degradation, the character of the cut edge of the suture, as well as the characteristics of the positioning holes of the PC-IOLs., Results: Scanning electron microscopy of the explanted suture revealed sharply cut edges, without significant degradation of the suture, and no intact loop. Scanning electron microscopy of the control suture cut with a PC-IOL demonstrated a similarly cut edge. The positioning holes of the examined PC-IOLs had a sharp edge, and some also had an imperfect finish., Conclusion: We conclude that the surface properties of the positioning holes lead to cutting of the suture, and subsequent subluxation of the PC-IOL.
- Published
- 2007
- Full Text
- View/download PDF
211. Bridging the gap in managing dry eye disease: a consensus report by the Taiwan society of cataract and refractive surgeons.
- Author
-
Sun, Chi-Chin, Hsu, Shiuh-Liang, Liang, Chang-Min, Tsai, Yi-Yu, and Lin, Pei-Yu
- Subjects
DRY eye syndromes ,EYE diseases ,REPORTING of diseases ,CATARACT surgery ,CATARACT ,SURGEONS ,DIAGNOSIS methods - Abstract
Background: An impaired ocular surface presents substantial challenges in terms of planning for cataract surgery. As a multifactorial ocular disorder, dry eye disease (DED) is common in the general population and prevalent in patients scheduled for lens replacement surgery. Cataract surgery can exacerbate DED and worsen several ocular parameters. Timely diagnosis and appropriate treatment of DED are vital to ensuring positive ophthalmic surgical outcomes. This consensus report of the Taiwan Society of Cataract and Refractive Surgeons (TSCRS) regarding the management of DED before, during, and after cataract surgery highlights the gaps between clinical guidelines and several aspects of DED, including diagnostic testing, diagnostic criteria, and clinical practice treatment. Methods: An expert panel of five specialists in the field of ophthalmology was recruited to develop consensus statements regarding the management of DED in both the general population and in patients undergoing cataract surgery in Taiwan. Two separate meetings of the five specialists, who were endorsed by the TSCRS, were convened for this purpose. A survey questionnaire consisting of binary or multiple-choice questions was developed through a consensus-driven formulation process. A percentage value was calculated for each statement, and a minimum of 60% agreement (equivalent to three out of five members) was required to achieve consensus. The second discussion meeting involved the presentation of the finalized consensus statements and concluded the consensus development process. Lastly, the finalized consensus statements were approved by all the experts, and the formulated recommendations for DED in the general population and prospective cataract surgery patients were accordingly presented. Results: The optimal algorithm for managing DED in the general population and in patients scheduled for cataract surgery was developed to address the unmet needs of this cohort in Taiwan. Conclusion: This report provides recommendations for managing dry eye disease. It is essential to screen and confirm DED through endorsed questionnaires and tests and then diagnose it. Treatment and management of DED should follow a stepwise approach. Screening and diagnosing DED is also recommended before cataract surgery. After cataract surgery, relatively aggressive treatment strategies are recommended to manage DED effectively. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
212. On modeling tear breakup dynamics with a nematic lipid layer.
- Author
-
Taranchuk, M. J. and Braun, R. J.
- Abstract
One of the main roles of the lipid layer (LL) of the tear film (TF) is to help prevent evaporation of the aqueous layer (AL). The LL thickness, composition, and structure all contribute to its barrier function. It is believed that the lipid layer is primarily nonpolar with a layer of polar lipids at the LL/AL interface. There is evidence that the nonpolar region of the LL may have liquid crystalline characteristics. We investigate the structure and function of the LL via a model of the tear film with two layers, using extensional flow of a nematic liquid crystal for the LL and shear-dominated flow of a Newtonian AL. Evaporation is taken into account and is affected by the LL thickness, internal arrangement of its rod-like molecules, and external conditions. We conduct a detailed parameter study with a focus on the evaporative resistance parameter, the Marangoni number, and primary liquid crystal parameters including the Leslie viscosities and director angle. This new model responds similarly to previous Newtonian models in some respects; however, incorporating internal structure via the orientation of the liquid crystal molecules affects both evaporation and flow. As a result, we see new effects on TF dynamics and breakup. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
213. Primary Sjögren's syndrome: new perspectives on salivary gland epithelial cells.
- Author
-
Hou, Jiaqi, Feng, Yiyi, Yang, Zhixia, Ding, Yimei, Cheng, Dandan, Shi, Zhonghao, Li, Rouxin, and Xue, Luan
- Subjects
SJOGREN'S syndrome ,SALIVARY glands ,EPITHELIAL cells ,EXOCRINE glands ,AUTOIMMUNE diseases ,CELL physiology - Abstract
Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease primarily affecting exocrine glands such as the salivary glands, leading to impaired secretion and sicca symptoms. As the mainstay of salivation, salivary gland epithelial cells (SGECs) have an important role in the pathology of pSS. Emerging evidence suggests that the interplay between immunological factors and SGECs may not be the initial trigger or the sole mechanism responsible for xerostomia in pSS, challenging conventional perceptions. To deepen our understanding, current research regarding SGECs in pSS was reviewed. Among the extensive aberrations in cellular architecture and function, this review highlighted certain alterations of SGECs that were identified to occur independently of or in absence of lymphocytic infiltration. In particular, some of these alterations may serve as upstream factors of immuno-inflammatory responses. These findings underscore the significance of introspecting the pathogenesis of pSS and developing interventions targeting SGECs in the early stages of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
214. Potential therapeutic effects of peroxisome proliferator-activated receptors on corneal diseases.
- Author
-
Bing Jie Chow, Isabelle Xin Yu Lee, Chang Liu, and Yu-Chi Liu
- Published
- 2024
- Full Text
- View/download PDF
215. Effects of common eye diseases in children and their treatment measures on ocular surface homeostasis: A review.
- Author
-
Zongyue Lv, Zhengyang Tao, Jing He, Jiao Wang, Zhihong Lin, Zefeng Kang, and Hongwei Deng
- Published
- 2024
- Full Text
- View/download PDF
216. SPARC overexpression in allogeneic adipose-derived mesenchymal stem cells in dog dry eye model induced by benzalkonium chloride.
- Author
-
Li, Chenchen, Li, Balun, Han, Miao, Tian, Hongkai, Gao, Jiaqi, Han, Dongyao, Ling, Zixi, Jing, Yuanxiang, Li, Na, and Hua, Jinlian
- Subjects
DRY eye syndromes ,BENZALKONIUM chloride ,ELECTRIC batteries ,WORKING dogs ,MESENCHYMAL stem cells ,EYE inflammation - Abstract
Background: Nowadays, companion and working dogs hold significant social and economic importance. Dry eye, also known as dry keratoconjunctivitis (KCS), a common disease in ophthalmology, can readily impact a dog's working capacity and lead to economic losses. Although there are several medications available for this disease, all of them only improve the symptoms on the surface of the eye, and they are irritating and not easy to use for long periods of time. Adipose-derived mesenchymal stem cells (ADMSC) are promising candidates for tissue regeneration and disease treatment. However, long-term in vitro passaging leads to stemness loss of ADMSC. Here, we aimed to use ADMSC overexpressing Secreted Protein Acidic and Rich in Cysteine (SPARC) to treat 0.25% benzalkonium chloride-treated dogs with dry eye to verify its efficacy. For in vitro validation, we induced corneal epithelial cell (HCECs) damage using 1 µg/mL benzalkonium chloride. Methods: Fifteen male crossbred dogs were randomly divided into five groups: normal, dry eye self-healing control, cyclosporine-treated, ADMSC-CMV-treated and ADMSC-OESPARC-treated. HCECs were divided into four groups: normal control group, untreated model group, ADMSC-CMV supernatant culture group and ADMSC-OESRARC supernatant culture group. Results: SPARC-modified ADMSC had the most significant effect on canine ocular surface inflammation, corneal injury, and tear recovery, and the addition of ADMSC-OESPARC cell supernatant also had a salvage effect on HCECs cellular damage, such as cell viability and cell proliferation ability. Moreover, analysis of the co-transcriptome sequencing data showed that SPARC could promote corneal epithelial cell repair by enhancing the in vitro viability, migration and proliferation and immunosuppression of ADMSC. Conclusion: The in vitro cell test and in vivo model totally suggest that the combination of SPARC and ADMSC has a promising future in novel dry eye therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
217. Application of Artificial Intelligence in Ophthalmology: An Updated Comprehensive Review.
- Author
-
Hashemian, Hesam, Peto, Tunde, Ambrósio Jr, Renato, Lengyel, Imre, Kafieh, Rahele, Noori, Ahmed Muhammed, and Khorrami-Nejad, Masoud
- Abstract
Artificial intelligence (AI) holds immense promise for transforming ophthalmic care through automated screening, precision diagnostics, and optimized treatment planning. This paper reviews recent advances and challenges in applying AI techniques such as machine learning and deep learning to major eye diseases. In diabetic retinopathy, AI algorithms analyze retinal images to accurately identify lesions, which helps clinicians in ophthalmology practice. Systems like IDx- DR (IDx Technologies Inc, USA) are FDA-approved for autonomous detection of referable diabetic retinopathy. For glaucoma, deep learning models assess optic nerve head morphology in fundus photographs to detect damage. In age-related macular degeneration, AI can quantify drusen and diagnose disease severity from both color fundus and optical coherence tomography images. AI has also been used in screening for retinopathy of prematurity, keratoconus, and dry eye disease. Beyond screening, AI can aid treatment decisions by forecasting disease progression and anti-VEGF response. However, potential limitations such as the quality and diversity of training data, lack of rigorous clinical validation, and challenges in regulatory approval and clinician trust must be addressed for the widespread adoption of AI. Two other significant hurdles include the integration of AI into existing clinical workflows and ensuring transparency in AI decisionmaking processes. With continued research to address these limitations, AI promises to enable earlier diagnosis, optimized resource allocation, personalized treatment, and improved patient outcomes. Besides, synergistic human-AI systems could set a new standard for evidence-based, precise ophthalmic care. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
218. Clinical Manifestations and Outcomes of Ocular Graft Versus Host Disease following Allogeneic Stem Cell Transplantation.
- Author
-
Shetty, Vijay, Kashelkar, Priyanka, Punatar, Sachin, Haldipurkar, Suhas, Hoshing, Abhishek, Thakur, Rasika, Sankhe, Prachi, Tanwar, Shabnam, Haldipurkar, Tanvi, Setia, Maninder Singh, Gokarn, Anant, Nayak, Lingaraj, Bonda, Avinash, and Khattry, Navin
- Abstract
Purpose: To evaluate clinical presentation of chronic ocular graft-versus-host disease (GVHD), laterality of presentation, and longitudinal changes in patients undergoing allogeneic stem cell transplantation. Methods: This is a retrospective longitudinal analysis of 60 eyes from 30 patients who had undergone hematopoietic stem cell transplantation. Demographic characteristics, clinical history, comorbidities, and other organ involvements were taken into account for analysis. We also undertook complete evaluation of the eyes, including cornea and anterior segment, posterior segment, Schirmer test, tear break-up time, ocular surface disease index, and intraocular pressure. Results: The mean age of the patients was 34.3 ± 11 years. The mean time for the diagnosis of ocular GVHD was 232.8 days (95% CI: 153.6, 311.9). The common findings at the first visit were bilateral blepharitis (n = 5, 17%), meibomitis (n = 4, 13%), and conjunctival congestion (n = 3, 10%). While bilateral cataract was present in one (3%) patient at the first visit, at 18 months, five (17%) patients had bilateral cataract and one (3%) patient had unilateral cataract. Grade 1 (n = 17), grade 2 (n = 9), and grade 3 (n = 4) superficial punctate epithelial erosions (SPEEs) were also observed at the first visit. However, SPEEs were seen in only 11 eyes at 18 months; all of these cases were grade 1 SPEEs. Long-term findings included cataract, telangiectasia, blepharospasm, conjunctival congestion, grade 1 SPEEs, corneal filaments, and tear film debris. Conclusion: Although the initial presentations were SPEEs, meibomitis, blepharitis, and conjunctival congestion, these inflammatory conditions were reduced over time with proper management. However, there was an increase in the proportion of patients with cataract. It is important to regularly monitor these patients in order to identify and manage the initial as well as the late ocular manifestations of chronic GVHD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
219. Fallbericht über das Sjögren-Syndrom mit Autoimmunhepatitis.
- Author
-
Caretti, Rachael, Wojtas, Caroline, Baniasadi, Mojdeh, Milis, Liana, and Scott, Randy
- Subjects
DIAGNOSIS - Abstract
Das Sjögren-Syndrom (SS) ist das Ergebnis einer abnormalen Immunreaktion des Körpers, die zur Zerstörung exokriner Drüsen führt, insbesondere der Augen- und Speicheldrüsen, was Xerophthalmie und Xerostomie zur Folge hat. Wir beschreiben den Fall einer 55-jährigen Frau, die sich mit auffälligen Leberfunktionswerten in der Klinik vorstellte. Nach umfangreichen Untersuchungen wurden bei der Patientin eine Autoimmunhepatitis (AIH) und ein SS diagnostiziert. Eine AIH tritt bei einer kleinen Anzahl von Patienten mit primärem SS auf, und es gibt nur wenige Studien über eine mögliche Überschneidung dieser beiden Autoimmunerkrankungen. In diesem Bericht werden einige der Herausforderungen bei der Diagnose einer AIH und der Identifizierung von SS als zugrunde liegender Diagnose dargestellt. Die Diagnose der AIH kann aufgrund des unklaren klinischen Bildes schwierig sein, insbesondere bei begleitenden Autoimmunerkrankungen. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
220. A comprehensive overview of diagnosis, imaging and treatment of vitreoretinal lymphoma.
- Author
-
Menean, Matteo, Giuffrè, Chiara, Cicinelli, Maria Vittoria, Marchese, Alessandro, Modorati, Giulio, Bandello, Francesco, and Miserocchi, Elisabetta
- Published
- 2024
- Full Text
- View/download PDF
221. Boston Keratoprosthesis type 1 (KPro) without contact lens wearing in end-stage corneal disease: The APEC experience.
- Author
-
De Wit-Carter, Guillermo, Hernández-Chavarría, César, Navarro-Naranjo, Pedro-Ivan, Manzanillo-Rosario, Cristal, Navarro-Saucedo, Ricardo, García-Albisua, Ana Mercedes, Hernandez-Quintela, Everardo, Cabrera-Martínez, Emmanuel, Ordoñez-Ranz, Gabriela, and Sanchez-Huerta, Valeria
- Published
- 2024
- Full Text
- View/download PDF
222. Corneal thickness and endothelial change after use of ocular hypotensive agents.
- Author
-
Lai, Hung‐Yin, Lai, Hung‐Chi, Kuo, Ming‐Tse, Tsai, Yi‐Yu, and Lai, Ing‐Chou
- Subjects
ANTIHYPERTENSIVE agents ,CORNEA ,VISION ,CORNEAL transplantation ,CORNEAL dystrophies ,ENDOTHELIAL cells ,OPEN-angle glaucoma - Abstract
Corneal transplantation can restore visual function when visual impairment is caused by a corneal disease. However, this treatment is associated with the scarcity of cornea donors. The suitability of corneal donation from patients with glaucoma using ocular hypotensive agents (OHAs) is controversial. This study aimed to elucidate changes in corneal thickness, corneal endothelial cell density, and corneal endothelial cell hexagonality after OHA use in patients with primary open‐angle glaucoma. We retrospectively reviewed the data of 53 glaucoma suspect eyes without OHA use and 106 primary open‐angle glaucoma eyes under OHA use. All participants underwent corneal parameter assessment using SP‐3000P (Topcon Corp., Tokyo, Japan) at the time of diagnosis and the final visit. The OHA dose and timing of use were recorded. The ocular hypotensive agents score (OHAS) was determined based on the number, formula, frequency, and duration of OHA use. Baseline data showed no significant differences between the two groups with and without OHA use. At the final visit, the OHA‐treated group showed significantly lower corneal thickness and corneal endothelial cell density than those of the control group. A weak positive correlation between the OHAS and changes in corneal endothelial cell hexagonality was noted. However, no correlation was observed between the OHAS and changes in corneal thickness or endothelial cell density. In conclusion, patients with glaucoma and using OHAs should undergo the corneal structural properties examinations before donation to ensure the quality of donor cornea. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
223. Corneal Epithelial Thickness in Sjogren's Disease: A Pilot Study.
- Author
-
Nguyen, Brian J, Gupta, Angela S, He, Jocelyn, Ying, Gui-Shuang, Bunya, Vatinee Y, Macchi, Ilaria, and Massaro-Giordano, Mina
- Subjects
SJOGREN'S syndrome ,CORNEA ,PILOT projects - Abstract
Objective and subjective measurements of ocular surface disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
224. Re-Esterified Triglyceride ω-3 Fatty Acids in Dry Eye Disease With Meibomian Gland Dysfunction: A Randomized Clinical Trial.
- Author
-
Eom, Youngsub, Jun, Ikhyun, Jeon, Hyun Sun, Lim, Dong Hui, Lee, Hun, Hwang, Ho Sik, Chung, So-Hyang, Chung, Tae-Young, Kim, Jae Yong, Kim, Sun Woong, Choi, Chul Young, Song, Jong Suk, Kim, Mee Kum, Seo, Kyoung Yul, and Hyon, Joon Young
- Published
- 2024
- Full Text
- View/download PDF
225. Prevalence of Dry Eye Disease in Laser-Assisted In Situ Keratomileusis Candidates.
- Author
-
Cartes, Cristian, Aravena, Camila, Monsalve, Alejandro, Segovia, Christian, Romero, Cristobal, Quidel, Daniela, Cid, Fernanda, Monsalve, Rudy, Navarro, Luis, Araya, Daniela, Araneda, Daniela, and Sepulveda, Maylyn
- Published
- 2024
- Full Text
- View/download PDF
226. The Effects of Type 2 Diabetes Mellitus on Meibomian Gland Morphology and Tear Film Parameters: Cross-Sectional Study.
- Author
-
ÖZBEK UZMANa, Selma, YALNIZ AKKAYA, Züleyha, OMMA, Tülay, ŞANLI, Alper, TÜFEKÇİ BALIKÇI, Ayşe, FIRAT, Sevde Nur, and BURCU, Ayşe
- Subjects
TYPE 2 diabetes ,MEIBOMIAN glands ,RETINAL diseases ,DRY eye syndromes ,CONTROL groups - Abstract
Copyright of Türkiye Klinikleri Journal of Ophthalmology is the property of Turkiye Klinikleri and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
227. Intense pulsed light treatment for the management of meibomian gland dysfunction.
- Author
-
Gupta, Angela Satya, Massaro, Mina, and Bunya, Vatinee Y.
- Published
- 2024
- Full Text
- View/download PDF
228. Comparison of Safety and Efficacy of Four-Point Scleral Intraocular Lens Fixation and the Yamane Technique.
- Author
-
Błagun, Natalia, Krix-Jachym, Karolina, and Rękas, Marek
- Subjects
INTRAOCULAR lenses ,VITREOUS body ,VISUAL acuity ,REFRACTIVE errors ,MILITARY medicine - Abstract
Introduction: The purpose of our study was to compare the safety and efficacy of two scleral fixation intraocular lens (IOL) methods of four-point scleral fixation (Akreos AO60) and the Yamane technique (AcrySof MA60AC). Methods: This prospective, randomized study was conducted at the Military Institute of Medicine—National Research Institute in Warsaw between 2021 and 2023. We compared both groups for cause of aphakia, ocular history, refractive status, and complication. Results: Our study included 50 eyes from 47 patients. Four-point fixation was performed in 25 eyes (group 1), and the Yamane technique was used in 25 eyes (group 2). Surgical time was 24.1 min ± 8.9 in group 1 and 25.1 min ± 9.9 in group 2 (p > 0.05). The postoperative BCVA (best-corrected visual acuity) for group 1 and group 2 at 1 year's observation was 0.10 ± 0.15 and 0.09 ± 0.17 logMAR, respectively (p > 0.05). Postoperative total refractive error (RE) was − 0.06 ± 0.71 diopters (D) for four-point scleral fixation and 0.83 ± 0.70 D for Yamane technique (p < 0.05). Endothelial cell density (ECD) loss was 0.9% in group 1 and 3.5% in group 2 (p > 0.05). Bleeding into the anterior chamber and vitreous body was more frequent in the group of patients operated on with the use of the Yamane technique (10 cases, 20%, p = 0.01). IOL displacement was found in one case (2%) in group 2. Conclusions: Both analyzed techniques are well tolerated and ensure good refractive results (extremely predictable in four-point scleral fixation) and have a similar safety profile. Four-point scleral fixation of IOL would appear to be safe, effective and beneficial for young, active patients, especially after trauma or recurrent subluxation. Clinical Trial Registration: ClinicalTrials.gov identifier NCT06389643. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
229. Interleukin-1β activates matrix metalloproteinase-2 to alter lacrimal gland myoepithelial cell structure and function.
- Author
-
Junji Morokuma, Gárriz, Angela, Toribio, Danny, Pagni, Sarah, and Zoukhri, Driss
- Published
- 2024
- Full Text
- View/download PDF
230. Probiotic LB101 alleviates dry eye in mice by suppressing matrix metalloproteinase-9 expression through the regulation of gut microbiota-involved NF-κB signaling.
- Author
-
Ma, Xiaoyang, Shin, Yoon-Jung, Yun, Soo-Won, Jang, Seok Won, Han, Seung-Won, and Kim, Dong-Hyun
- Subjects
DRY eye syndromes ,CONJUNCTIVA ,FECAL microbiota transplantation ,LACRIMAL apparatus ,BIFIDOBACTERIUM bifidum ,PROBIOTICS - Abstract
Tear matrix metalloproteinase (MMP)-9 is an inflammatory signal in patients with dry eye (DE). In the present study, to understand the action mechanism of probiotic LB101 (Lactobacillus plantarum NK151 and Bifidobacterium bifidum NK175 [4:1] mix) against DE, we investigated its effect on tear amount and inflammatory marker expression levels in mice with unilateral exorbital lacrimal gland excision/atropine-benzalkonium chloride application (EB) or fecal microbiota transplantation from mice with EB (eFMT). Oral gavage of LB101 increased EB-suppressed tear amount and decreased EB-induced blinking number. Furthermore, LB101 decreased EB-induced TNF-α, IL-1β, and MMP-9 expression, TNF-α
+ and NF-κB+ CD11c+ cell populations, and edema in the conjunctiva, while EB-suppressed IL-10 and occludin expression increased. LB101 also decreased EB-induced TNF-α and IL-1β expression and NF-κB+ CD11c+ cell population in the colon. eFMT also decreased tear amount and increased blinking number in the transplanted mice. eFMT increased TNF-α, IL-1β, and MMP-9 expression and TNF-α+ and NF-κB+ CD11c+ cell populations in the conjunctiva and TNF-α and IL-1β expression and NF-κB+ CD11c+ cell populations in the colon. Oral gavage of LB101 increased eFMT-suppressed tear amount and decreased eFMT-induced blinking number. Furthermore, LB101 decreased TNF-α, IL-1β, and MMP-9 expression, TNF-α+ and NF-κB+ CD11c+ cell populations, and edema in the conjunctiva and TNF-α and IL-1β expression and NF-κB+ CD11c+ cell population in the colon, while eFMT-suppressed IL-10 and occludin expression decreased. Furthermore, LB101 increased eFMT-suppressed Muribaculaceae, Prevotellaceae, and Lactobacillaceae populations in the gut microbiota, while eFMT-induced Bacteroidaceae population decreased. These findings suggest that DE may cause gut dysbiosis, which may be a risk factor for DE, and LB101 may alleviate DE with gut inflammation by suppressing the expression of MMP-9 and proinflammatory cytokines TNF-α and IL-1β with the regulation of gut microbiota-involved NF-κB signaling. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
231. Biopolymer-based nano-formulations for mitigation of ocular infections: a review.
- Author
-
Karati, Dipanjan, Mukherjee, Swarupananda, Singh, Sudarshan, Prajapati, Bhupendra G., and Basu, Biswajit
- Subjects
INTRAOCULAR drug administration ,NANOSTRUCTURED materials ,DRUG delivery systems ,BIOAVAILABILITY ,RF values (Chromatography) ,POLYMER clay ,NANOSCIENCE ,LOW vision - Abstract
Ocular infirmities significantly influence a person's routine process by impairing vision to the point of blindness. Effective ocular drug administration with significant bioavailability is challenging due to physiology and defensive mechanisms, which is majorly due to inadequate epithelial permeability and quick removal of the drug from the eye after administration. Due to the numerous restrictions on drug distribution across the blood–retinal barrier, conventional medicines cannot provide definitive therapy for all ocular illnesses, making it a significant clinical issue. However, significant breakthroughs in the management of ocular disorders have been made possible by the use of biopolymeric drug transport with nanoscience. The use of biopolymers in ophthalmic medications has produced several positive effects, including safety, prolonged retention times, improved bioavailability, and controlled release via adhesion to epithelia. Moreover, therapeutic implementation of nanostructure materials, from diagnosis to therapy, has also received significant attention. This evolving biopolymer-based nanoscale drug delivery system has enhanced the drug's ability to pass through various ocular barriers with improvement in bioavailability. Among other beneficial characteristics, biodegradable polymers offer amended retention period and extended release. This review emphasizes the various biopolymer-based fabricated nano-formulations used to mitigate ocular infection. Biopolymer-based nano-formulations for targeted delivery of drugs against ocular infections [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
232. Preliminary study of cyclosporine A/Lifitegrast subconjunctival sustained-release drug membrane in the treatment of dry eyes.
- Author
-
Yang, Jie, Chen, Miao, Wu, Fangyuan, Zuo, Jingjing, and Ma, Huixiang
- Published
- 2024
- Full Text
- View/download PDF
233. Assessment of causal relationships between omega-3 and omega-6 polyunsaturated fatty acids in autoimmune rheumatic diseases: a brief research report from a Mendelian randomization study.
- Author
-
Xiao Xu, Xu Xu, Zakeri, Mohammad Ali, Shu-Yun Wang, Min Yan, Yuan-Hong Wang, Li Li, Zhi-ling Sun, Rong-Yun Wang, and Lin-Zhong Miao
- Published
- 2024
- Full Text
- View/download PDF
234. Efficacy of RCI001 as a therapeutic candidate of dry eye disease in a modified mixed dry eye model.
- Author
-
Jung, Young-ho, Ku, Young Ah, Moon, Jayoon, Kim, Seunghoon, Ryu, Jin Suk, Yoon, Chang Ho, Chung, Myung Hee, Kim, Yong Ho, Kim, Mee Kum, and Kim, Dong Hyun
- Published
- 2024
- Full Text
- View/download PDF
235. An LC-MS/MS method for the determination of Lifitegrast in human plasma and tear and its application in the pharmacokinetic study.
- Author
-
Juan, Cai, Qi, Wen, Min, Yang, Boping, Wei, Weixun, Lv, Xingxiang, Lv, Xiaorong, He, Xiao, Ke, and Daiguo, Zhao
- Published
- 2024
- Full Text
- View/download PDF
236. An experimental model for primary neuropathic corneal pain induced by long ciliary nerve ligation in rats.
- Author
-
Jinhong Wu, Tianjie Yuan, Danyun Fu, Rui Xu, Wenna Zhang, Shuangshuang Li, Jiahui Ding, Lili Feng, Ying Xi, Jijiang Wang, Wenxian Li, and Yuan Han
- Published
- 2024
- Full Text
- View/download PDF
237. Current Status of Shared Decision-Making in Intraocular Lens Selection for Cataract Surgery: A Cross-Sectional Study.
- Author
-
Dai, Jingyao, Hua, Yiting, Chen, Yijie, Huang, Jiali, Zhang, Xiaoxian, Sun, Yiwen, Chen, Chen, Chen, Yanyan, and Zhou, Kaijing
- Subjects
INTRAOCULAR lenses ,CATARACT surgery ,OPERATIVE surgery ,PATIENT education ,CROSS-sectional method ,PHACOEMULSIFICATION - Abstract
Purpose: To explore 1) the level of shared decision-making (SDM) participation in intraocular lens (IOL) selection in cataract patients and the factors that influence this participation and 2) the relationships between preparation for decision-making (PrepDM)and the level of SDM participation and satisfaction with the decision (SWD). Provide guidance for improving SDM in ophthalmology. Patients and Methods: 176 cataract patients were asked to complete the PrepDM scale, the 9-item Shared Decision Making Questionnaire (SDM-Q-9) and the SWD instrument in IOL decision-making process. Multiple linear regression was used to analyze the influencing factors of the level of SDM. The Process program and bootstrap sampling method was used to test whether the level of participation in SDM was a mediating variable among the three. Results: The SDM-Q-9 median score was 77.78 (IQR 31.11– 88.89). Patients with a history of surgery in the operative eye (P=0.022) or PrepDM < 60 points (P< 0.001) had lower SDM-Q-9 scores than patients with no history of surgery in the operative eye or PrepDM ≥ 60 points. Patients with an education level lower than primary school had lower SDM-Q-9 scores than patients with other education levels (P< 0.05). The PrepDM of cataract patients was positively correlated with the level of SDM (r=0.768, P< 0.001) and with the SWD (r=0.727, P< 0.001), and the level of SDM was positively correlated with the SWD (r=0.856, P< 0.001). The level of SDM fully mediated PrepDM and SDW, with a mediating effect value of 0.128 and a mediating effect of 86.66% of the total effect. Conclusion: The SDM of cataract patients involved in IOL selection was in the upper middle range. Education, history of surgery in the operated eye, and PrepDM were factors that influenced the level of SDM. The level of participation in SDM fully mediated the relationship between PrepDM and SWD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
238. Influential Signs of Dry Eye--Related Ocular Symptoms in Participants With Unstable Tear Film.
- Author
-
Jiahui Shen, Zhiqiang Xu, Yuzhou Wang, Jingjian Ye, Linzhi Wei, Jiahui Xia, Yiran Sun, Fan Lu, and Liang Hu
- Published
- 2024
239. Tissue Engineering and Ophthalmology.
- Author
-
Utine, Canan Aslı and Güven, Sinan
- Subjects
EYE physiology ,GENE therapy ,MEDICAL technology ,TISSUE engineering ,EYE diseases ,OPHTHALMOLOGY ,MEDICAL research ,DRUG development - Abstract
Tissue engineering (TE) is a field of science that combines biological, engineering, and medical sciences and allows the development of disease models, drug development and gene therapy studies, and even cellular or tissue-based treatments developed by engineering methods. The eye is an organ that is easily accessible and amenable to engineering applications, paving the way for TE in ophthalmology. TE studies are being conducted on a wide range of topics, including the tear film, eyelids, cornea, optic nerve, glaucoma, and retinal diseases. With the rapid scientific advances in the field, it seems that TE is radically modifying the management of ocular disorders. : [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
240. Patient-Reported Dry Eye Treatment and Burden of Care.
- Author
-
Nau, Cherie B., Nau, Amy C., Fogt, Jennifer S., Harthan, Jennifer S., Shorter, Ellen S., and Schornack, Muriel M.
- Published
- 2024
- Full Text
- View/download PDF
241. Effect of Corneal and Lens Eccentricity Difference on Rigid Corneal Lens Treatment in Patients With Keratoconus.
- Author
-
Younga Kwon, Sang Beom Han, Song-A Che, Kyungmin Koh, So Young Han, Chul Young Choi, and Yong Woo Lee
- Published
- 2024
- Full Text
- View/download PDF
242. Varenicline Solution Nasal Spray for the Treatment of Dry Eye Disease Following LASIK.
- Author
-
Ferguson, Tanner J., Messer, Brooke, Risbrudt, Nicholas, Stofferahn, Seth, and Greenwood, Michael
- Subjects
DRY eye syndromes ,INTRANASAL medication ,LASIK ,VARENICLINE ,SPRAY drying ,OPHTHALMIC surgery ,PHOTOREFRACTIVE keratectomy - Abstract
Introduction: The purpose of this study is to evaluate the use of a varenicline solution nasal spray (VNS) for reducing the signs and symptoms of dry eye following laser in situ keratomileusis (LASIK). Methods: Subjects electing to undergo LASIK were randomized to VNS (study group) or placebo/vehicle (control group) and initiated treatment with the nasal spray twice daily 28 days prior to surgery with continued treatment for 84 days following LASIK. After initiation of treatment, subjects were seen on the day of surgery and postoperatively on Days 1, 7, 28, 84 (3 months) and 168 (6 months). The primary outcome measure was the mean change in NEI-VFQ-25, a 25-item dry eye questionnaire, from baseline to 3 months. The second primary outcome measure was the mean change in corneal fluorescein staining. Secondary outcome measures included evaluation of tear break-up time, Schirmer testing, tear osmolarity and eye dryness score (EDS). Results: Twenty subjects were enrolled in each group and successfully underwent LASIK. Both groups demonstrated an improvement in the National Eye Institute Visual Function Questionnaire (NEI-VFQ) at 3 months. The study group demonstrated improved corneal staining scores at months 1 and 3. Similarly, the study group demonstrated improvement in tear osmolarity scores versus the placebo group at the same time points. Although the study group was numerically greater than placebo for each time point for both corneal staining and tear osmolarity, the differences were not statistically significant for any primary or secondary outcome measures. Conclusion: VNS is a dry eye treatment option for patients following LASIK and may have potential benefit for patients hoping to avoid additional topical medications. The results were not statistically significant compared to placebo in this trial, and further investigation of the use of VNS following LASIK in a larger trial would be beneficial. Plain Language Summary: Laser in situ keratomileusis (LASIK) is a very successful refractive surgery option for patients hoping to reduce or eliminate their need for spectacles. Signs and symptoms of dry eye disease are very common after LASIK owing to the transection of corneal nerves that occurs during the procedure, and many patients are advised to manage it with frequent instillation of artificial tears. This study evaluated the use of a varenicline solution nasal spray, a recently introduced pharmacologic option that stimulates natural tear production through activation of the trigeminal nerve pathway. This is the first study to evaluate the use of the varenicline solution nasal spray in patients after refractive surgery and demonstrates that it could represent a favorable, ocular surface-sparing option for patients to minimize the signs and symptoms of dry eye following LASIK, a procedure known to trigger symptoms of dry eye disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
243. Using 2% PVPI topical solution for serial intravitreous injections and ocular surface findings: a case control study.
- Author
-
Casemiro, José Henrique, Oguido, Ana Paula Miyagusko Taba, and Casella, Antonio Marcelo Barbante
- Subjects
INTRAVITREAL injections ,INJECTIONS ,MENISCUS injuries ,DRY eye syndromes ,POVIDONE-iodine ,MEIBOMIAN glands - Abstract
Background: The use of povidone-iodine for ocular surface asepsis is widespread for intravitreal injections. They became frequent procedures, leading to serial exposure of patients' eyes to iodinated solutions. In this study, we investigate the changes in the ocular surface in patients submitted to repeated use of povidine for intravitreal injection of anti-VEGF asepsis, analyzing Ocular Surface Disease Index, non-invasive break up time, blinking quality, lipid layer, meniscus height and osmolarity. Methods: This case-control study included 34 individuals (68 eyes), 14 males, 20 females aged 48 to 94. Inclusion criteria were individuals who received application of 2% povidone-iodine eyedrops for intravitreal injections treatment with the non-treated contralateral eye used as control. Ocular surface examinations were performed at a single occasion. A pre-intravitreal injection asepsis protocol with povidone-iodine was applied. All statistical analysis was performed using the STATA® 18.0 Software and a p-value = 0.05 was considered as the statistical significance value in all tests. Results: The median number of IVIs in treated eyes was 12 (range 6–20). The results in treated eyes compared with untreated eyes were respectively : median OSDI 16 (IQR 6–39) and 12.5 (IQR 8–39) (p = 0.380); mean NIBUT 10.30 (SD ± 2.62) and 10.78 (SD ± 2.92) (s, p = 0.476); median blinking quality 100 (IQR 100) and 100 (IQR 100) (%, p = 0.188); median lipid layer 87 (IQR 77–90) and 86 (IQR 74–100) (nm, p = 0.451); median meniscus height 0.22 (IQR 0.19-0,31) and 0.24 (IQR 0.20–0.27) (mm, p = 0.862), median Meibomian gland atrophy 33 (IQR 24–45) and 31.5 (IQR 25–39) (%, p = 0.524); and mean osmolarity 306.6 (SD ± 21.13) and 313.8 (SD ± 29) (mOsm, p = 0.297). There was no statistically significant relationship between the repetitive use of 2% iodinated solution and signs or symptoms compatible with dry eye syndrome in this group of patients. Conclusions: The findings suggest that 2% povidone iodine is a safe and efficacious agent for ocular surface antisepsis during intravitreal injections, not leading to substantial ocular surface modifications. This conclusion supports the continued use of povidone iodine in routine ophthalmic procedures without increased risk of inducing dry eye syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
244. Studies on cationic ocular emulsions containing bipartitioned oil droplets to codeliver cyclosporin A and etodolac.
- Author
-
Ruhina Rahman, Syed Nazrin, Goswami, Abhinab, Jala, Aishwarya, Venuganti, Animith, Deka, Apurba, Borkar, Roshan M, Singh, Vivek, Das, Dipankar, and Shunmugaperumal, Tamilvanan
- Abstract
Background: To prepare ocular emulsions containing bipartitioned oil droplets to entrap cyclosporin A (0.05% w/w) and etodolac (0.2% w/w) by using castor, olive and silicon oils. Methods: The physicochemical characterizations of prepared emulsions were performed. The drug's biodistribution profiles and pharmacokinetic parameters from emulsions were checked using the ultraperformance liquid chromatography–tandem mass spectrometry method in the ocular tissues of the healthy rabbit eye model. Results: The emulsions displayed 365.13 ± 7.21 nm size and 26.45 ± 2.09 mV zeta potential. The ferrying of two drugs after releasing from emulsions occurred across corneal/conjunctival tissues to enter the vitreous and sclera following a single drop administration into the rabbit's eyes. Conclusion: The dual drug-loaded emulsions were more likely to produce synergistic anti-inflammatory activity for managing moderate-to-severe dry eye disease. Summary points Ocular emulsion eyedrops containing bipartitioned oil droplets to entrap cyclosporin A (CsA) and etodolac (Edc) were prepared using castor, olive and silicon oils. The mean particle size, polydispersity index and zeta potential values observed for emulsions were 365.13 ± 7.21 nm, 0.282 ± 0.03 and 26.45 ± 2.09 mV, respectively. The drug-entrapment efficiency values of 77–82% were found for CsA and Edc in emulsions. A faster Edc release from emulsions was observed compared with CsA release in 7.4 pH simulated tear fluid. The combination index value of 0.806 computed from the in vitro protein denaturation assay indicates synergism in the anti-inflammatory activity of emulsions. The cell viability (%) values of 95.710 ± 2.78 to 99.263 ± 0.92% were noticed in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay using human corneal epithelial cells. The ultraperformance liquid chromatography–tandem mass spectrometry bioanalytical method was utilized for the simultaneous estimation of CsA and Edc in ocular tissues of healthy rabbit eyes. The highest area under the curve from 0 to 90 min time period (AUC
0-90 min ) values were obtained for CsA from emulsions in the cornea followed by conjunctiva, sclera, vitreous and aqueous humor. The highest AUC0-90 min values were found for Edc from emulsion in the cornea, followed by the sclera, conjunctiva, aqueous humor and vitreous. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
245. Chemokines and lymphocyte homing in Sjögren's syndrome.
- Author
-
Jiahe Liao, Xinbo Yu, Ziwei Huang, Qian He, Jianying Yang, Yan Zhang, Jiaqi Chen, Weijiang Song, Jing Luo, and Qingwen Tao
- Subjects
SJOGREN'S syndrome ,JAK-STAT pathway ,CELL adhesion molecules ,CHEMOKINES ,LYMPHOCYTES - Abstract
Sjögren's syndrome (SS) is a chronic systemic autoimmune disease that typically presents with lymphocyte, dendritic cell, and macrophage infiltration of exocrine gland ducts and the formation of ectopic germinal centers. The interactions of lymphocyte homing receptors and addressins and chemokines and their receptors, such as a4b7/MAdCAM-1, LFA-1/ICAM-1, CXCL13/CXCR5, CCL25/ CCR9, CX3CL1/CX3CR1, play important roles in the migration of inflammatory cells to the focal glands and the promotion of ectopic germinal center formation in SS. A variety of molecules have been shown to be involved in lymphocyte homing, including tumor necrosis factor-a, interferon (IFN)-a, IFN-b, and B cell activating factor. This process mainly involves the Janus kinase-signal transducer and activator of transcription signaling pathway, lymphotoxin-b receptor pathway, and nuclear factor-kB signaling pathway. These findings have led to the development of antibodies to cell adhesion molecules, antagonists of chemokines and their receptors, compounds interfering with chemokine receptor signaling, and gene therapies targeting chemokines and their receptors, providing new targets for the treatment of SS in humans. The aim of this study was to explore the relationship between lymphocyte homing and the pathogenesis of SS, and to provide a review of recent studies addressing lymphocyte homing in targeted therapy for SS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
246. The outcomes of corneal sight rehabilitating surgery in Stevens-Johnson syndrome: case series.
- Author
-
Peng, Rongmei, Chi, Miaomiao, Xiao, Gege, Qu, Hongqiang, Shen, Zhan, Zhao, Yinghan, and Hong, Jing
- Subjects
STEVENS-Johnson Syndrome ,CORNEA ,LOW vision ,CORNEAL transplantation ,AMNION ,SURGICAL complications - Abstract
Purpose: To summarize the outcomes of corneal sight rehabilitating surgery in Stevens-Johnson syndrome (SJS). Methods: This is a retrospective analysis of a consecutive case series. Twenty-four eyes of 18 SJS patients were included in this study. The ocular parameters, surgical procedures, postoperative complications, and additional treatments of the cases were reviewed. Results: A total of 29 corneal sight rehabilitating surgeries, which consists of 9 keratoplasties, 8 Keratolimbal allograft (KLAL) and 12 combined surgeries (keratoplasty and KLAL simultaneously) were performed on the 24 eyes. All patients were treated with glucocorticoid eyedrops and tacrolimus eyedrops for anti-rejection treatment without combining systemic immunosuppression, except two patients who were prescribed prednisone tablets for the management of systemic conditions. The mean follow-up period was 50.6 ± 28.1 months. The optimal visual acuity (VA) (0.74 ± 0.60 logarithm of the minimum angle of resolution [logMAR]) and endpoint VA (1.06 ± 0.82 logMAR) were both significantly better than the preoperative VA (1.96 ± 0.43 logMAR) (95% CI, p = 0.000). 57.1% patients (8/14) were no longer in the low vision spectrum, and 88.9% patients (8/9) were no longer blind. The mean epithelialization time was 7.1 ± 7.6 weeks. The success rate was 86.7%. Additional treatments for improving epithelialization included administration of serum eyedrops (n = 10), contact lens (n = 15), amniotic membrane transplantation (n = 6), and tarsorrhaphy (n = 8). Complications included delayed epithelialization (n = 4, over 12 weeks), glaucoma (n = 11), and severe allograft opacity (n = 4). Only one graft rejection was observed. Conclusions: Keratoplasty and KLAL can remarkably enhance VA and improve low vision or even eliminate blindness for ocular complications of SJS. The outcome of the surgeries was correlated with the preoperative ocular situation and choice of operative methods. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
247. A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial.
- Author
-
Gioia, Neda, Gerson, Jeffry, Ryan, Robert, Barbour, Krista, Poteet, Julie, Jennings, Brooke, Sharp, Matthew, Lowery, Ryan, Wilson, Jacob, Morde, Abhijeet, Ra, Deshanie, Padigaru, Muralidhara, and Periman, Laura M.
- Published
- 2024
248. Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive Strategies.
- Author
-
Biao Li, Kaiyao Chi, Haoran Li, Jing Wang, and Yanlin Zheng
- Published
- 2024
- Full Text
- View/download PDF
249. Comparative study of the reptilian cornea's microstructure.
- Author
-
Abdelftah, Zeinab, Ragab, Ahmed, Abo-Eleneen, Rasha E., Abuelsaad, Abdelaziz S., and EL-Bakry, Ahlam M.
- Subjects
GREEN turtle ,SCANNING electron microscopy ,EPITHELIAL cells ,CORNEA ,RETINAL imaging ,CHAMELEONS - Abstract
Background: The cornea of various vertebrate is considered a major part in the glop, which acts as a powerful lens, providing a sharp retinal image, and meantime acts as an excellent defensor for other corneal layers. Results: The four reptilian families [Scincidae (Chalcides ocellatus); Chamaeleontidae (Chameleon chameleon); Cheloniidae (Chelonia mydas) and Testudiniae (Testudo kleinmanni)] investigated in the current study were gathered across Egypt. After being taken out of the orbit, the cornea under inquiry was ready for light, specific stain and scanning electron microscopy. The epithelium, stroma, and endothelium are the three corneal layers that are common to all four species of reptiles. All other species lack Bowmen's and Descemet's membranes, with the exception of C. ocellatus and T. kleinmanni. The latter layers of Chalcides ocellatus display a strong affinity for Periodic Acid Schiff stain. Epithelial cells with a variety of forms, from hexagonal to atypical polygonal cells, cover the outer corneal surface. These epithelial cells are coated in short microplicae, microvilli, and microholes of varied diameters. There are a few blebs scattered around their surface. Conclusion: The current study concluded that various habitats have various significant effects on the cornea's microstructure characteristics and its physiological trends to accommodate different environmental surroundings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
250. Obesity, body fat distribution and eye diseases.
- Author
-
Bosello, Francesca, Vanzo, Angiola, Zaffalon, Chiara, Polinelli, Luca, Saggin, Filippo, Bonacci, Erika, Pedrotti, Emilio, Marchini, Giorgio, and Bosello, Ottavio
- Subjects
OBESITY ,CHRONIC diseases ,EYE diseases ,BODY composition ,ADIPOSE tissues - Abstract
Background: The prevalence of obesity, a chronic disease, is increasing, and obesity is now considered a global epidemic. Eye diseases are also increasing worldwide and have serious repercussions on quality of life as well as increasingly high costs for the community. The relationships between obesity and ocular pathologies are not yet well clarified and are not pathologically homogeneous: they seem to be somehow linked to excess body fat, especially to the distribution of adipose tissue and its ectopic deposits. Purpose: Our objective was to examine the associations between obesity and anthropometric indices, including body mass index (BMI), waist circumference (WC), and the waist/hip ratio (WHR), and the risk of most widespread eye diseases, with particular attention given to the most significant metabolic mechanisms. Methods: This article provides a narrative overview of the effect of obesity and anthropometric measurements of body fat on prevalent eye diseases. We used the MEDLINE/PubMed, CINAHL, EMBASE, and Cochrane Library databases from 1984 to 2024. In addition, we hand-searched references from the retrieved articles and explored a number of related websites. A total of 153 publications were considered. Results: There is significant evidence that obesity is associated with several eye diseases. Waist circumference (WC) and the waist/hip ratio (WHR) have been observed to have stronger positive associations with eye diseases than BMI. Conclusions: Obesity must be considered a significant risk factor for eye diseases; hence, a multidisciplinary and multidimensional approach to treating obesity, which also affects ocular health, is important. In the prevention and treatment of eye diseases related to obesity, lifestyle factors, especially diet and physical activity, as well as weight changes, both weight loss and weight gain, should not be overlooked. Level of evidence: Level V narrative review. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.